The European Molecular Biology Laboratory (EMBL) is Europe's esteemed lab network for research in molecular biology. EMBL is funded by 20 member states an one associate member. EMBL operates in 5 sites, the main laboratory is in Heidelberg, Germany. Additionally, EMBL manages the European Bioinformatics Institute in Hinxton, Grenoble, Hamburg and Monterotondo near Rome, Italy. Research at EMBL covers the entire spectrum of research in molecular biology. The mission of EMBL is to train scientists at all levels, perform basic molecular biology research and to create new instruments and methods in the broad field of life science and technology development. EMBL has a PhD program and currently has 170 candidates in the program. EMBL publishes updates news about their current research and welcomes the public and media to visit or connect with them about their work.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
Imagine building a traffic surveillance camera that could detect trouble-making cells speeding around in your brain before their cellular gang could commit "crimes." Most importantly, this camera could catch some of the biggest ...
Sep 10, 2024
0
1
Failure is the most likely outcome of a clinical trial. Learning from these failures by understanding which factors maximize the chances of a successful trial would help improve the drug discovery process. However, accessing ...
Aug 1, 2024
0
16
At any given time, over 10 trillion microbes call our guts their home. From breaking down nutrients in our food to strengthening our immunity against pathogens, these microbes play an essential role in how we interact with ...
Jul 31, 2024
0
145
Each second of our lives, cells in our body grow and divide to ensure we stay healthy. However, this process has a dark side: if cell growth and divisions become excessive, that may cause cancer. To keep a safe balance, our ...
Jun 19, 2024
0
13
Blood stem cells from healthy people carry major chromosomal alterations, suggesting we are all genetic mosaics, according to a new study from EMBL and the Max Delbrück Center.
May 28, 2024
0
17
Scientists from EMBL's European Bioinformatics Institute (EMBL-EBI) and the German Cancer Research Center (DKFZ) have used Danish health registries to predict individual risks for the 20 most common types of cancer.
May 23, 2024
0
8
A study from the Hackett group at the European Molecular Biology Laboratory (EMBL) in Rome shows that disrupting the gut microbiome of male mice increases the risk of disease in their future offspring.
May 1, 2024
0
49
Inflammatory bowel diseases (IBDs), such as Crohn's disease or ulcerative colitis, arise when there is a dysregulation of the cell signaling pathways controlling the maintenance of homeostasis in the gut, leading to a chronic ...
Oct 26, 2023
0
0
In an extensive investigation, EMBL researchers have tested over 10,000 drug combinations against some of the leading pathogenic bacteria carrying antimicrobial resistance and causing mortality
Oct 17, 2023
0
16
A new study has shed light on why immunotherapy does not always work in certain types of cancer. Led by researchers at EMBL's European Bioinformatics Institute (EMBL-EBI), Cold Spring Harbor Laboratory (CSHL), and the Massachusetts ...
Sep 14, 2023
0
25
